• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB

DIMERIX LIMITED - Charts / Financials

2.90% ! 35.5¢
Market Cap $207.1M  !
Healthcare Biotechnology
Add to My Watchlist

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

refresh Created with Sketch. REFRESH
Last update - 16.10pm 16/03/2026 (20 minute delay) ?
Day
Open 34.0¢   Day High 37.0¢   Day Low 33.5¢
Daily Volume 1471053
Bids   Sellers
Number Price Volume   Number Price Volume
0 35.0¢ 20460   0 35.5¢ 20110

Directors & Senior Management

Dr. Alessia Fornoni Member of Medical Advisory Board
Mr. Clinton Snow Non-Executive Director
Dr. Daniel Cattran Member of Medical Advisory Board
Dr. David Everett Fuller Chief Medical Officer
Prof. David Power Member of Medical Advisory Board
Mr. Hamish George CFO & Company Secretary
Mr. Hugh Alsop Independent Non-Executive Director
Dr. Jonathan J. Hogan Member of Medical Advisory Board
Mr. Kevin Donald George Pfleger Chief Scientific Advisor
Dr. Laura Mariani Member of ACTION3 Medical Advisory Board
Mr. Mark Diamond Non-Executive Chairman
Dr. Nina Webster CEO, MD & Director
Mr. Robert Shepherd Chief Operating Officer
Dr. Sonia Maria Poli Non Executive Director

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
35.5¢ 		Change
0.010(2.90%) 		Mkt cap ! $207.1M
Open High Low Volume
34.0¢ 37.0¢ 33.5¢ 1.471M

Buyers (Bids)

Vol. Price($)
20460 35.0¢
 

Sellers (Offers)

Price($) Vol.
35.5¢ 20110
Last trade - 16.10pm 16/03/2026 (20 minute delay) ?

Top Stories

Listen: HotCopper Wire Podcast #045 – That -4% heart attack, and all the oil chaos

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson run through another Iran-centric episode, including the ASX’s mega dumps and big jumps on all the global news, as well as Trump, the widening Middle East conflict, and how we see the Reserv...
Alligator Energy: Perfectly positioned for next wave of Aussie uranium production Global powers everywhere are grappling with decarbonisation and energy security, especially as nuclear power has transitioned from a side discussion to a central pillar of the @Net Zero” transition ⁠@ and this is exactly why Alligator Energy (ASX:AGE), deep in South ...
West Cobar makes strategic licence applications in NSW West Cobar Metals continues to expand its holdings around the Bulla Park project in central New South Wales.
ASX Today: RBA call looming, Iran War unchanged, gold @ US$5K flat – so XJO errs on side of caution Greetings and welcome to HotCopper’s The ASX Today, I’m Jon Davidson, and while the XJO tried to break green at lunch, it couldn’t quite get there. Heading into the latter half of arvo trades, we’re down half a percent in the face of...
Oneview Healthcare to raise $21M to back AI developments Oneview Healthcare is raising $21 million to support its pipeline of AI backed developments and new applications.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.